PCa development involves activation of multiple oncogenic signaling pathways such as AR and c-Myc, and miR-34a upregulation, like elevated LRIG1 expression, might well represent a feedback inhibitory mechanism to antagonize oncogenic signals driven by MYC and AR (see below). Here, LRIG1 is linked to posterior cortical atrophy.